Enanta Pharmaceuticals
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 145
- Market Cap
- $275.6M
- Introduction
Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also con...
Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects
- First Posted Date
- 2021-05-04
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 24
- Registration Number
- NCT04871724
- Locations
- 🇺🇸
Pharmaceutical Research Associates, Inc.,, Salt Lake City, Utah, United States
A Study to Evaluate EDP 938 Regimens in Children With RSV
- First Posted Date
- 2021-03-25
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 96
- Registration Number
- NCT04816721
- Locations
- 🇺🇸
Memorial Care Miller Children's and Women's Hospital, Long Beach, California, United States
🇺🇸University of California Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸UC Davis, Sacramento, California, United States
Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 72
- Registration Number
- NCT04783753
- Locations
- 🇺🇸
Pharmaceutical Research Association, Lenexa, Kansas, United States
Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract
- Conditions
- Interventions
- First Posted Date
- 2020-11-18
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 9
- Registration Number
- NCT04633187
- Locations
- 🇺🇸
Augusta University Medical Center, Augusta, Georgia, United States
🇬🇷Evangelismos General Hospital of Athens, Athens, Greece
🇹🇷Ege Universitesi Tip Fakultesi Hastanesi, Bornova, Izmir, Turkey
A Study of EDP-297 in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2020-09-22
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 82
- Registration Number
- NCT04559126
- Locations
- 🇳🇱
PRA Health Sciences, Groningen, Netherlands
Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2020-08-04
- Last Posted Date
- 2021-10-13
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 89
- Registration Number
- NCT04498741
- Locations
- 🇺🇸
Pharmaceutical Research Associates, Inc.,, Lenexa, Kansas, United States
A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 25
- Registration Number
- NCT04470388
- Locations
- 🇨🇳
E-Da Hospital/E-DA Cancer Hospital, Kaohsiung, Taiwan
🇨🇳Changhua Christian Hospital, Changhua, Taiwan
🇨🇳China Medical University Hospital, Taichung, Taiwan
A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH
- Conditions
- Interventions
- First Posted Date
- 2020-05-07
- Last Posted Date
- 2023-05-19
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 98
- Registration Number
- NCT04378010
- Locations
- 🇺🇸
Paradigm Clinical Research Institute, Torrance, California, United States
🇺🇸Universal Axon Clinical Research, Doral, Florida, United States
🇺🇸San Marcus Research Clinic, Inc., Miami Lakes, Florida, United States
A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects
- First Posted Date
- 2019-12-12
- Last Posted Date
- 2023-10-30
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 82
- Registration Number
- NCT04196101
- Locations
- 🇿🇦
Clinical Projects Research SA pty Ltd, Worcester, Western Cape, South Africa
🇺🇸Central Alabama Research, Birmingham, Alabama, United States
🇺🇸Saint Joseph's Clinical Research, Anaheim, California, United States
A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 99
- Registration Number
- NCT04008004
- Locations
- 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States
🇺🇸American Research Corporation, Houston, Texas, United States
🇨🇦Toronto General Hospital, Toronto, Ontario, Canada